0

Coronary Risk Factors Collection
 101-120 of 207 Articles
ACP Journal Club |  19 April 2011
Review: Varenicline is better than placebo or bupropion, but not clearly different from the nicotine patch, for smoking abstinence
James Brophy, MD, PhD
Ann Intern Med. 2011;154(8):JC4-4. doi:10.7326/0003-4819-154-8-201104190-02004
ACP Journal Club |  15 March 2011
Elevated HbA1c levels (5.7% to 6.4%) had low accuracy for diagnosing prediabetes
Yogish C. Kudva, MD; Ananda Basu, MD
Ann Intern Med. 2011;154(6):JC3-11. doi:10.7326/0003-4819-154-6-201103150-02011
ACP Journal Club |  15 February 2011
Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes
Rozalina Grubina, MD; Steven A. Smith, MD
Ann Intern Med. 2011;154(4):JC2-13. doi:10.7326/0003-4819-154-4-201102150-02013
ACP Journal Club |  15 February 2011
Pharmacist–physician hypertension comanagement reduced 24-hour ambulatory blood pressure
Brett D. Montgomery, MBBS, DCH, FRACGP
Ann Intern Med. 2011;154(4):JC2-9. doi:10.7326/0003-4819-154-4-201102150-02009
ACP Journal Club |  21 December 2010
Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI
Herbert D. Aronow, MD, MPH
Ann Intern Med. 2010;153(12):JC6-13. doi:10.7326/0003-4819-153-12-201012210-02013
ACP Journal Club |  16 November 2010
Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes
David L. Bronson, MD, FACP
Ann Intern Med. 2010;153(10):JC5-10. doi:10.7326/0003-4819-153-10-201011160-02010
ACP Journal Club |  16 November 2010
Intensive glucose control did not reduce a composite of microvascular events more than standard control in type 2 diabetes
David C. Aron, MD, MS; Leonard M. Pogach, MD, MBA
Ann Intern Med. 2010;153(10):JC5-9. doi:10.7326/0003-4819-153-10-201011160-02009
ACP Journal Club |  16 November 2010
Review: Erythropoiesis-stimulating agents targeted to higher hemoglobin levels increase risk for adverse outcomes in CKD
Chi-yuan Hsu, MD, MSc
Ann Intern Med. 2010;153(10):JC5-3. doi:10.7326/0003-4819-153-10-201011160-02003
ACP Journal Club |  19 October 2010
Review: Vibration testing and monofilament testing are most accurate for diagnosing large-fiber peripheral neuropathy in diabetes
David R. Gutknecht, MD
Ann Intern Med. 2010;153(8):JC4-10. doi:10.7326/0003-4819-153-8-201010190-02010
ACP Journal Club |  19 October 2010
Aspirin alone or combined with nadroparin did not increase live birth rates in women with unexplained recurrent miscarriage
Christopher J. Robinson, MD, MSCR
Ann Intern Med. 2010;153(8):JC4-7. doi:10.7326/0003-4819-153-8-201010190-02007
ACP Journal Club |  19 October 2010
Prior intensive insulin treatment reduced long-term risk for peripheral neuropathy in type 1 diabetes
Mario Di Napoli, MD
Ann Intern Med. 2010;153(8):JC4-3. doi:10.7326/0003-4819-153-8-201010190-02003
ACP Journal Club |  19 October 2010
Benazepril plus amlodipine reduced CV events more than benazepril plus hydrochlorothiazide in hypertension with or without diabetes
Srinivas Merugu, MD
Ann Intern Med. 2010;153(8):JC4-2. doi:10.7326/0003-4819-153-8-201010190-02002
ACP Journal Club |  21 September 2010
Review: Treatment for gestational diabetes reduces risk for shoulder dystocia
Debra A. Guinn, MD
Ann Intern Med. 2010;153(6):JC3-6. doi:10.7326/0003-4819-153-6-201009210-02006
ACP Journal Club |  21 September 2010
Review: Statins do not reduce mortality in patients with no history of cardiovascular disease
David J. Maron, MD
Ann Intern Med. 2010;153(6):JC3-4. doi:10.7326/0003-4819-153-6-201009210-02004
ACP Journal Club |  17 August 2010
HbA1c levels ≤ 5.5% ruled out, and levels ≥ 7.0% ruled in, type 2 diabetes in clinical and community populations
Leonard Reeves, MD, FAAFP
Ann Intern Med. 2010;153(4):JC2-11. doi:10.7326/0003-4819-153-4-201008170-02011
ACP Journal Club |  20 July 2010
Higher “normal” glycated hemoglobin levels were associated with increased risk for diabetes, CVD, stroke, and mortality in adults
Steven A. Smith, MD
Ann Intern Med. 2010;153(2):JC1-13. doi:10.7326/0003-4819-153-2-201007200-02013
ACP Journal Club |  20 July 2010
Review: Metformin does not increase risk for lactic acidosis in type 2 diabetes
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2010;153(2):JC1-9. doi:10.7326/0003-4819-153-2-201007200-02009
ACP Journal Club |  20 July 2010
Fenofibrate plus simvastatin did not prevent major CV events more than simvastatin alone in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-5. doi:10.7326/0003-4819-153-2-201007200-02005
ACP Journal Club |  20 July 2010
Intensive blood pressure control did not prevent major CV events more than standard control in type 2 diabetes
C. Raina Elley, MBChB, PhD; Vanessa Selak, MBChB, MPH
Ann Intern Med. 2010;153(2):JC1-4. doi:10.7326/0003-4819-153-2-201007200-02004
ACP Journal Club |  15 June 2010
Aspirin did not prevent vascular events or mortality in adults with a low ankle–brachial index
A.C. Felix Burden, MD
Ann Intern Med. 2010;152(12):JC6-11. doi:10.7326/0003-4819-152-12-201006150-02011
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)